Cancer Immunology and Oncolytic Virology: Technologies and Global Markets
WEST HARTFORD, Conn., April 14, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Cancer Immunology and Oncolytic Virology: Technologies and Global Markets" at GIIResearch.com
This report, PHM129A Cancer Immunology and Oncolytic Virology: Technologies and Global Markets provides an overview of the current and potential global market for cancer immunotherapy and virology. The report provides comprehensive information on a number of the most common cancers, highlighting global incidence and prevalence. It identifies the need for more effective drugs for treatment of these diseases. The key objective is to present a comprehensive analysis of the current state of cancer immunotherapy and where this field is going. A second objective is to examine the current state of oncolytic virology and where this nascent field appears to be heading. Important trends in each field, clinical trials and results, new developments and sales forecasts for cancer immunotherapy from 2011 through 2018 are provided in this report. In addition, sales forecasts are presented for oncolytic virology covering the years 2011 through 2023. Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics and other factors that directly affect the cancer market. The report also addresses opportunities for future players.
The scope of this study entails the current immunology therapeutics markets for several of the most common cancers. The sectors covered are colony stimulating factors (CSFs), interferon alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Also covered is oncolytic virology, so new that its market tables have been presented separately from the immunotherapy tables. The report also includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials.
Table of Contents
CHAPTER 1 - INTRODUCTION
CHAPTER 2 - SUMMARY
CHAPTER 3 - OVERVIEW
CHAPTER 4 - OVERVIEW OF CANCER IMMUNOTHERAPY
CHAPTER 5 - ONCOLYTIC VIROTHERAPY
CHAPTER 6 - MAJOR MARKETS
CHAPTER 7 - TECHNOLOGY
CHAPTER 8 - COMPANY PROFILES
LIST OF TABLES AND FIGURES
More detailed information is available at
Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, USemail@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.